Welcome to our dedicated page for COHERENT SEC filings (Ticker: COHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Coherent Corp. filings document the formal disclosures of a Pennsylvania operating company whose common stock trades on the New York Stock Exchange under COHR. Recent Form 8-K reports cover quarterly operating results, Regulation FD investor materials, executive transition matters, shareholder-vote results and capital-structure events.
The filing record also documents securities registered under Section 12(b), a completed private placement of common stock to NVIDIA, Series B convertible preferred stock and a dividend-rights waiver by its holder. These disclosures connect Coherent's photonics operations with governance, ownership, financing and reporting matters, including exhibits furnished with earnings releases and investor presentations.
FMR LLC filed Amendment No. 1 to Schedule 13G, reporting beneficial ownership of Coherent Corp. common stock. The filing lists 12,851,209.51 shares beneficially owned, representing 8.2% of the class as of the event date 09/30/2025.
FMR LLC reports sole voting power over 12,675,992.95 shares and sole dispositive power over 12,851,209.51 shares, with no shared voting or dispositive power. Abigail P. Johnson is also a reporting person, disclosing sole dispositive power over 12,851,209.51 shares and no voting power. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Coherent Corp. (COHR) insider activity: the company’s EVP, General Management, reported option exercises and open‑market sales on 10/29/2025.
He exercised options to acquire 14,640 shares at $35.25, 17,760 shares at $49.90, and 27,080 shares at $36.56. He then sold 47,751 shares at a weighted average price of $140.4618 (range $140.00–$140.99) and 11,729 shares at a weighted average price of $141.1017 (range $141.00–$141.30). The sales were made under a Rule 10b5‑1 trading plan adopted on December 6, 2024.
Following these transactions, his directly held beneficial ownership was 223,864 shares.
Coherent Corp. (COHR) reported an insider transaction on Form 4. A company director sold 2,000 shares of common stock at $140 on 10/29/2025, coded “S.” The sale was made under a Rule 10b5-1 trading plan adopted on 11/21/2024.
Following the transaction, the reporting person beneficially owns 22,108 shares, held directly.
COHR: A Form 144 notice discloses a proposed sale of 2,000 shares of COHR common stock with an aggregate market value of $268,480, expected around 10/29/2025. The proposed broker is Morgan Stanley Smith Barney LLC, and the shares trade on the NYSE.
The securities were acquired as Restricted Stock Units on 07/05/2022 in the amount of 2,000. Recent activity shows 10b5-1 sales for Stephen Skaggs: 2,000 shares on 10/24/2025 for $260,000 and 2,000 shares on 08/13/2025 for $244,460. Shares outstanding were 155,805,474.
COHR filed a Form 144 notice for a proposed sale of 59,480 shares of common stock with an aggregate market value of $7,984,595.20. The shares were acquired on 10/29/2025 via cash exercise of stock options from the issuer, with an approximate sale date of 10/29/2025 through Morgan Stanley Smith Barney LLC on the NYSE.
Shares outstanding are 155,805,474. Form 144 is a notice of intent to sell restricted or control securities under Rule 144.
Coherent Corp. (COHR) director reported an open‑market sale of common stock. On 10/24/2025, the reporting person sold 2,000 shares at a price of $130 per share under transaction code “S.” The filing indicates the trade was made pursuant to a Rule 10b5‑1 trading plan adopted on November 21, 2024.
Following the transaction, the reporting person beneficially owned 24,108 shares, held in direct ownership.
Coherent (COHR): Form 144 notice of proposed sale. A stockholder filed to sell up to 2,000 shares of Coherent common stock through Morgan Stanley Smith Barney. The filing lists an aggregate market value of $243,040 for the proposed sale, with an approximate sale date of 10/24/2025 on the NYSE.
The shares were acquired as Restricted Stock Units on 07/05/2022 from the issuer in the amount of 2,000. As context, shares outstanding were 155,805,474. The filing also reports a prior sale during the past three months: 2,000 common shares on 08/13/2025 for gross proceeds of $244,460 under a noted 10b5-1 sales entry for Stephen Skaggs.
Coherent Corp. (COHR) filed a Form 4 disclosing a tax withholding transaction tied to RSU vesting. On 10/21/2025, the reporting person had 5,618 shares withheld under code F at $120.2 per share to satisfy taxes, a non‑open‑market action. Following the transaction, the insider directly owns 48,208 shares.
The withholding relates to RSUs granted on October 21, 2024 that vest in three equal annual installments beginning October 21, 2025. 13,029 shares vested on 10/21/2025, with 26,059 remaining to vest. The reporting person is an officer (EVP, Legal).
Coherent Corp. (COHR) CFO reported a routine tax-withholding transaction tied to equity vesting. On 10/11/2025, the officer had 18,558 shares of common stock withheld under transaction code F at a price of $111.1 per share to satisfy taxes upon restricted stock unit (RSU) vesting. Following the transaction, the officer beneficially owns 76,475 shares directly.
The filing notes an RSU grant of 79,056 shares on 10/11/2024: 15,902 RSUs vest in three equal annual installments beginning 10/11/2025, and 63,154 RSUs vest in two equal annual installments beginning the same date. A total of 36,877 shares vested on 10/11/2025, with 42,179 shares remaining to vest. The company states the withheld shares discharge tax obligations and do not represent an open-market sale.
Coherent Corp. amended its credit agreements, adding a temporary step-up to a 4.75 to 1.00 interest coverage covenant for the four quarters following any material acquisition while remaining subject to a baseline 2.50 to 1.00 interest coverage covenant. The covenants apply to the revolving facility (including 2025 Revolving Loans) and Term A loans (including 2025 Incremental Term A Loans). Remaining proceeds from the 2025 Incremental Term A Loans were used to pay fees and expenses tied to Amendment No. 4, and will be used for working capital and general corporate purposes. The filing is signed by the company’s Chief Legal and Global Affairs Officer.